Disease gene identification based on generic and disease-specific genome networks

Abstract

Summary Immune diseases have a strong genetic component with Mendelian patterns of inheritance. While the tight association has been a major understanding in the underlying pathophysiology for the category of immune diseases, the common features of these diseases remain unclear. Based on the potential commonality among immune genes, we design Gene Ranker for key gene identification. Gene Ranker is a network-based gene scoring algorithm that initially constructs a backbone network based on protein interactions. Patient gene expression networks are added into the network. An add-on process screens the networks of weighted gene co-expression network analysis (WGCNA) on the samples of immune patients. Gene Ranker is disease-specific; however, any WGCNA network that passes the screening procedure can be added on. With the constructed network, it employs the semi-supervised learning for gene scoring. Results The proposed method was applied to immune diseases. Based on the resulting scores, Gene Ranker identified potential key genes in immune diseases. In scoring validation, an average area under the receiver operating characteristic curve of 0.82 was achieved, which is a significant increase from the reference average of 0.76. Highly ranked genes were verified through retrieval and review of 27 million PubMed literatures. As a typical case, 20 potential key genes in rheumatoid arthritis were identified: 10 were de facto genes and the remaining were novel. Availability and Implementation Gene Ranker is available at http://www.alphaminers.net/GeneRanker/ Supplementary information Supplementary data are available at Bioinformatics online.

Significance-based multi-scale method for network community detection and its application in disease-gene prediction

“…Network module analysis is an important method for biomedical network research [65]. Here, we apply the multi-scale significance method to some hot issues in current computational biology: the disease-gene identification [66]. Identifying disease-related genes is of interest in the study of molecular https://doi.org/10.1371/journal.pone.0227244.g011…”

Comparative mRNA/micro-RNA co-expression network drives melanomagenesis by promoting epithelial–mesenchymal transition and vasculogenic mimicry signaling

“…These methods are typically data-driven and do not consider any biological information of the component genes as input; nonetheless, they have the advantage of identifying the distinguishing features without having any biological information about those features. In this regard, weighted gene co-expression network analysis (WGCNA) is a new biological construction method offering an alternative approach to discover new biomarkers for melanoma based on the known functions and interactions of individual molecules [ 17 , 18 ]. Furthermore, WGCNA has the added advantage of combining condition-specific transcriptome data and allowing the understanding of the functional role of individual genes and other biological molecules such as microRNAs (miRNAs), which have the capability of discriminating between diseased and healthy cells or between different melanoma stages [18] .…”

Discovering comorbid diseases using an inter-disease interactivity network based on biobank-scale PheWAS data

“…Second, we perform comorbidity score prediction: given a specific disease, we predict comorbidity of other diseases by applying graph-based SSL to the constructed network ( Lee et al , 2020 ; Nam et al , 2019a , b ). Since the network includes both synergistic and antagonistic associations (edge weights with positive and negative values), we posited the following hypotheses concerning comorbidity predictions: (i) two diseases have a chance of comorbidity if they are connected (i.e.…”